Page results
-
Tasnim tells us about her experience training with the Pharmacy team at UCLH and how their support has encouraged her to pursue this career.
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.
-
This page has information on how to treat iron overload with Desferrioxamine. It has information on how the medicine is delivered and how you can do it at home.
-
Information about the use of deferasirox iron chelation treatment for iron overload.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
-
This page explains what FACETS is and how it can help you.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
File results
-
FOI/2023/0119 - Post occupancy evaluations following completion of a capital project
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0142 - Treatment of breast cancer